Keywords
Hanseniasis
Cancer
Localization
Incidence
Cancer
Localization
Incidence
How to Cite
1.
WESHLER Z, SHESKIN J. Hanseniasis y cancer. Hansen. Int. [Internet]. 1983 Jun. 30 [cited 2024 Nov. 23];8(1):18-21. Available from: https://periodicos.saude.sp.gov.br/hansenologia/article/view/35583
Abstract
The number of patients treated for hanseniasis and cancer in Israel is not sufficient for a statistical analysis. A general conclusion about the incidence of cancer in hanseniasis patients has not been reached. The data presented may be perhaps useful for a comparison with those of other researchers interested in the subject.
References
1 GOOD, R.A. & FINSTAD, J. Essential relationship between the lymphoid system, immunity, and malignancy. Nat. Cancer Inst. Monogr. (31) :41-58, 1969.
2 KLINGMÜLLER, V. Die Lepra. In: JADASSOHN, J. Handbuch der Haut and Geschlechtskrankheiten. Berlin, Springer, 1930. v.10, pt.2.
3 KOSOLAPKEENA, L.I. & SAVEENICH, B.V. On the problem of malignant neoplasm frequency in lepra patients. Vop. Onkol., 4(1) :90-94, 1958.
4 MICHALANY, J. Malignant tumors of the skin among leprosy patients. Int. J. Lepr., 34(3):274-286, 1966.
5 OLEINICK, A. Altered immunity and cancer risk: a review of the problem and analysis of the cancer mortality experience of leprosy
patients. J. Nat. Cancer Inst., 43(4):775-781, 1969.
6 SOEGARD, M. Weitere Untersuchungen über die Krebssterblichkeit unter den Lepranken. Berlin. Klin. Wschr., 49: 1025-1030, 1912.
7 SOUTHAM, C.M. Relationship of immunology to cancer: a review. Cancer Res., 20(3):271-291, 1960.
8 TURK, J.L. Cell mediated immunological process in leprosy. Bull. Wld. Hlth. Org., 41:779-792, 1969.
9 WESHLER, Z.; LEVIATAN, A.; GORDON, R..; KOPOLOVIC, J. Development of Hodgkin's disease in a patient with leprosy. Oncology,
35:281-284, 1978.
2 KLINGMÜLLER, V. Die Lepra. In: JADASSOHN, J. Handbuch der Haut and Geschlechtskrankheiten. Berlin, Springer, 1930. v.10, pt.2.
3 KOSOLAPKEENA, L.I. & SAVEENICH, B.V. On the problem of malignant neoplasm frequency in lepra patients. Vop. Onkol., 4(1) :90-94, 1958.
4 MICHALANY, J. Malignant tumors of the skin among leprosy patients. Int. J. Lepr., 34(3):274-286, 1966.
5 OLEINICK, A. Altered immunity and cancer risk: a review of the problem and analysis of the cancer mortality experience of leprosy
patients. J. Nat. Cancer Inst., 43(4):775-781, 1969.
6 SOEGARD, M. Weitere Untersuchungen über die Krebssterblichkeit unter den Lepranken. Berlin. Klin. Wschr., 49: 1025-1030, 1912.
7 SOUTHAM, C.M. Relationship of immunology to cancer: a review. Cancer Res., 20(3):271-291, 1960.
8 TURK, J.L. Cell mediated immunological process in leprosy. Bull. Wld. Hlth. Org., 41:779-792, 1969.
9 WESHLER, Z.; LEVIATAN, A.; GORDON, R..; KOPOLOVIC, J. Development of Hodgkin's disease in a patient with leprosy. Oncology,
35:281-284, 1978.
This journal is licensed under a Creative Commons Attribution 4.0 International License.
Downloads
Download data is not yet available.
